It didn’t take long for the shine to come off one of biotech’s recent IPO success stories, with BioAge Labs scrapping a phase ...
In addition, the decline in overall obesity rate reported by the CDC isn’t the first such drop. Between 1999 and 2018, the ...
Results from a recent survey have prompted questions about the influence of GLP-1s on the obesity rate of U.S. adults.
Azelaprag, the company’s main clinical candidate, is an oral apelin receptor agonist designed to amplify the weight loss ...
Most of Israel "Izzy" Englander's favorite stocks these days are technology leaders. At least that's the conclusion you'd ...
BioAge Labs said on Friday it is discontinuing the mid-stage trial of its experimental obesity drug after high levels of ...
As demand for obesity drugs like Wegovy, Zepbound, Mounjaro and Ozempic, outpaces supply, online scams are rising, according ...
Shares in Amgen fell on Tuesday after they announced the results of a trial for their weight loss drug MariTide.
After losing and regaining the same 20-plus pounds more times than she could count, Anita Blanchard concluded that diets ...
Battling obesity requires a shift away from today’s reactive efforts. Enter Robert F. Kennedy Jr., the controversial nominee ...
The U.K. will start offering Eli Lilly’s weight loss drug next year, but will restrict the medicine to people with the ...
The biotech disclosed Friday plans to terminate a Phase 2 study testing azelaprag with tirzepatide for weight loss following ...